Literature DB >> 3722151

Evidence for multiple condensing enzymes in rat hepatic microsomes catalyzing the condensation of saturated, monounsaturated, and polyunsaturated acyl coenzyme A.

M R Prasad, M N Nagi, D Ghesquier, L Cook, D L Cinti.   

Abstract

The condensation of palmitoyl-CoA with malonyl-CoA by rat hepatic microsomes was competitively inhibited by myristoyl-CoA, whereas it was noncompetitively inhibited by palmitoleoyl and gamma-linolenoyl-CoA. Furthermore, the condensation of palmitoleoyl-CoA with malonyl-CoA was also noncompetitively inhibited by gamma-linolenoyl-CoA. Replacement of normal diet by a fat-free high carbohydrate diet resulted in 8-, 2.5-, and 2.3-fold increases in the condensation rates of both palmitoyl- and myristoyl-CoA, palmitoleoyl-CoA, and gamma-linolenoyl-CoA, respectively. On the other hand, administration of di-(2-ethylhexyl)phthalate (DEHP) resulted in a 2-fold stimulation of the condensation activities with myristoyl- and palmitoyl-CoA, while those with palmitoleoyl- and gamma-linolenoyl-CoA decreased to about 83 and 63%, respectively. Similar results following dietary changes or DEHP administration were obtained for total elongation activities. Finally condensation activities of 16:0, 16:1, and gamma-18:3 CoA were differently affected by the proteolytic enzyme, chymotrypsin. The competitive substrate studies, those of dietary and DEHP administration, and the differential action of chymotrypsin strongly suggest the existence of at least three discrete condensing enzymes catalyzing the condensation of saturated, monounsaturated, and polyunsaturated acyl-CoAs. These studies also indicate that the condensation reaction is the regulating and rate-limiting step of the fatty acid chain elongation system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722151

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases.

Authors:  Yun Wang; Daniela Botolin; Barbara Christian; Julia Busik; Jinghua Xu; Donald B Jump
Journal:  J Lipid Res       Date:  2005-01-16       Impact factor: 5.922

2.  Effects of fructose and troglitazone on phospholipid fatty acid composition in rat skeletal muscle.

Authors:  J N Clore; L Li; W B Rizzo
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

3.  Regulation by carbohydrate and clofibric acid of palmitoyl-CoA chain elongation in the liver of rats.

Authors:  Naomi Kudo; Tomoaki Toyama; Atsushi Mitsumoto; Yoichi Kawashima
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

4.  Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice.

Authors:  Young-Ah Moon; Robert E Hammer; Jay D Horton
Journal:  J Lipid Res       Date:  2008-10-06       Impact factor: 5.922

5.  Zebrafish cDNA encoding multifunctional Fatty Acid elongase involved in production of eicosapentaenoic (20:5n-3) and docosahexaenoic (22:6n-3) acids.

Authors:  Morris Agaba; Douglas R Tocher; Cathryn A Dickson; James R Dick; Alan J Teale
Journal:  Mar Biotechnol (NY)       Date:  2004-05-06       Impact factor: 3.619

6.  Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation.

Authors:  M Alegret; E Cerqueda; R Ferrando; M Vázquez; R M Sánchez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 7.  The fate and intermediary metabolism of stearic acid.

Authors:  Harini Sampath; James M Ntambi
Journal:  Lipids       Date:  2005-12       Impact factor: 1.880

8.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.

Authors:  Yun Wang; Daniela Botolin; Jinghua Xu; Barbara Christian; Ernestine Mitchell; Bolleddula Jayaprakasam; Muraleedharan G Nair; Muraleedharan Nair; Jeffrey M Peters; Jeffery M Peters; Julia V Busik; Julia Busik; L Karl Olson; Donald B Jump
Journal:  J Lipid Res       Date:  2006-06-21       Impact factor: 5.922

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.